Fisher Asset Management, LLC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 118 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$1,262,365
-10.4%
58,7420.0%0.00%0.0%
Q1 2023$1,409,220
+93040.8%
58,742
-9.9%
0.00%0.0%
Q4 2022$1,513
-99.9%
65,2190.0%0.00%0.0%
Q3 2022$1,045,000
-9.6%
65,2190.0%0.00%0.0%
Q2 2022$1,156,000
+12.6%
65,219
+29.4%
0.00%0.0%
Q1 2022$1,027,000
+38.8%
50,419
+27.3%
0.00%
Q4 2021$740,000
+84.1%
39,593
+94.6%
0.00%
Q3 2021$402,000
+12.6%
20,349
+34.8%
0.00%
Q2 2021$357,000
-0.3%
15,0950.0%0.00%
Q1 2021$358,000
+18.5%
15,0950.0%0.00%
Q4 2020$302,000
-30.4%
15,095
-27.6%
0.00%
Q3 2020$434,000
-10.1%
20,850
-24.5%
0.00%
Q2 2020$483,000
-17.3%
27,606
-22.8%
0.00%
-100.0%
Q1 2020$584,000
-20.7%
35,7440.0%0.00%0.0%
Q4 2019$736,000
+79.5%
35,7440.0%0.00%
Q3 2019$410,000
-12.8%
35,7440.0%0.00%
-100.0%
Q2 2019$470,000
-59.3%
35,744
-50.0%
0.00%0.0%
Q1 2019$1,155,000
+88.1%
71,488
+100.0%
0.00%0.0%
Q4 2018$614,000
+16.5%
35,7440.0%0.00%0.0%
Q3 2018$527,000
-54.7%
35,744
-26.7%
0.00%
-50.0%
Q2 2018$1,164,000
-24.8%
48,796
-19.4%
0.00%0.0%
Q1 2018$1,547,00060,5420.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2019
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$48,689,0002.30%
Camber Capital Management LP 1,050,000$19,614,0000.67%
OneAscent Wealth Management LLC 14,131$264,0000.66%
Eventide Asset Management 2,629,593$49,121,0000.63%
CLARK ESTATES INC/NY 183,800$3,433,0000.50%
Values First Advisors, Inc. 42,312$790,0000.47%
RICE HALL JAMES & ASSOCIATES, LLC 704,201$13,154,0000.47%
EMERALD MUTUAL FUND ADVISERS TRUST 650,398$12,149,0000.43%
OneAscent Financial Services LLC 11,774$220,0000.42%
Factorial Partners, LLC 33,300$622,0000.41%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders